Skip to content

Clinical efficacy of continuous non-invasive positive pressure ventilation sequential hyperbaric oxygen in the treatment for patients with acute severe carbon monoxide poisoning

Clinical efficacy of continuous non-invasive positive pressure ventilation sequential hyperbaric oxygen in the treatment for patients with acute severe carbon monoxide poisoning

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100052467
Enrollment
Unknown
Registered
2021-10-27
Start date
2015-01-01
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

carbon monoxide poisoning

Interventions

mask oxygen group:Nil
Non-invasive positive pressure ventilation group:Nil

Sponsors

Liaocheng People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients had a clear history of CO exposure and met the diagnostic criteria of severe CO poisoning: 1. The degree of disturbance of consciousness was deep coma or cerebral decortex state. 2. Patients with disturbance of consciousness and complicated with any of the following manifestations: brain edema; shock or severe myocardial damage; pulmonary edema; respiratory failure; upper gastrointestinal bleeding; brain lesion, such as impaired signs of pyramidal system or extrapyramidal system. 3. The concentration of COHB could reach as high as 50%. 4. Patients without contraindications of hyperbaric oxygen and noninvasive ventilator.

Exclusion criteria

Exclusion criteria: Patients with severe mental illness, severe cerebrovascular disease (such as cerebral hemorrhage or massive cerebral infarction), severe heart disease and severe respiratory disease before CO poisoning were excluded; patients with contraindications of hyperbaric oxygen and noninvasive ventilator, as well as mild and moderate CO poisoning were also excluded.

Design outcomes

Primary

MeasureTime frame
cure rate;

Secondary

MeasureTime frame
carboxyhemoglobin;The incidence of respiratory failure;Incidence of late-onset encephalopathy;consciousness recovery time;recovery of cadponin I;

Countries

China

Contacts

Public ContactYu Zhongkai

Liaocheng People's Hospital

yuzhongkai@yeah.net+86 18763525526

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026